Livewire Ergogenics Supports California Cannabis Tourism

New Post Public Reply Private Reply Replies (0) Message Board
louied91
522
Livewire Ergogenics Supports California Cannabis Tourism Efforts

https://www.globenewswire.com/news-release/20...forts.html

Anaheim, CA, June 09, 2022 (GLOBE NEWSWIRE) -- LiveWire Ergogenics Inc. (OTC: LVVV), a company focused on acquiring, managing, and licensing special purpose real estate properties conducive to producing high-quality, handcrafted, and organically sun-grown cannabis products for medical and recreational adult-use in California is accelerating its efforts to develop Estrella Ranch in Paso Robles into California’s premier Cannabis destination.

“Cannabis vacations or Canna-cations are not just for Stoners anymore,” says Forbes magazine on May 27, 2002. We at Livewire agree with the Forbes article wholeheartedly. Therefore, we are carving a somewhat different path than most cannabis operators in California and continue to develop Estrella Ranch into more than just a successful cultivation operation. More than producing the best organic sun-grown cannabis in the Country, we go ‘beyond the weed’ and are also focused on building the ultimate cannabis destination for cannabis tourism in California to experience the world’s first Estate Grown Weedery™ at Estrella Ranch. When feasible, Estrella Ranch will invite visitors to learn about sun-grown cannabis and experience the living and breathing organic style operation firsthand in a beautiful and safe environment.

LiveWire Ergogenics Inc. (LVVV) Stock Research Links

LVVV Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

USDA Under Scrutiny as ASPCA Reports on Puppy Mill Violations

Updated Category News Views 322

ASPCA's Shocking Report on Puppy Mill Violations In a recent analysis by the ASPCA, alarming statistics have surfaced regarding animal welfare violations at USDA-licensed commercial dog breeding facilities. The findings reveal that in a given year, substantial breaches of care standards were documented, yet no actions were taken to ensure the safety of the animals....

Continue Reading
PowerReviews Unveils Partner Program to Amplify UGC Value

Updated Category News Views 1653

PowerReviews Launches Comprehensive Partner Program PowerReviews, a reputable name backed by 1WorldSync, has initiated an exciting Partner Program aimed at revolutionizing the way user-generated content (UGC) is leveraged. This initiative is designed to not only boost productivity but also facilitate enhanced revenue opportunities for partners who promote its advanced...

Continue Reading
Turnspire Capital Partners Expands Portfolio with GHP Group

Updated Category News Views 81

Turnspire Capital Partners pulled the trigger on acquiring GHP Group back in 2024, a move that sent shockwaves through the consumer product landscape. This was no random buy; GHP's got its fingers in the pie of outdoor living products—think patio heaters and grills—all under reputable brands like Dyna-Glo and Pleasant Hearth. GHP Group: A Heavyweight Player in Outdoor...

Continue Reading
MPI Corporation Launches Groundbreaking 250 GHz Probe System

Updated Category News Views 187

Enhancing Precision in Semiconductor Testing In the fast-evolving world of semiconductor technology, precision and performance are critical. MPI Corporation has once again demonstrated its innovative spirit by unveiling a revolutionary 250 GHz broadband test solution. This state-of-the-art system combines the power of the TITAN™ Probes and MPI's extensive expertise in...

Continue Reading
Passage Bio's Gene Therapy Strategy: Hope for Dementia Treatments

Updated Category News Views 76

Promising Advances in Gene Therapy Recently, Passage Bio, Inc. (NASDAQ: PASG), a pioneering company in genetic medicine, showcased groundbreaking preclinical and interim clinical results for its gene therapy product, PBFT02. This was presented at a major congress focused on gene and cell therapy. Designed specifically to target frontotemporal dementia associated with GRN...

Continue Reading